- Supported exchanges /
- F /
- 4TZ.F
ORIC PHARMAC.INC.DL-0001 (4TZ F) stock market data APIs
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, which is designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study; and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, currently under Phase 1b study, being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms, including ORIC-613, an orally bioavailable, highly selective inhibitor of PLK4, in preclinical studies for the treatment of breast cancers. It has a license and collaboration agreement with Voronoi Inc.; a license agreement with Mirati Therapeutics, Inc.; and clinical development collaboration agreement with Pfizer Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
ORIC PHARMAC.INC.DL-0001 Financial Data Overview
| 7.8 | |
| 7.8 | |
| - | |
| 7.8 | |
| 7.8 | |
| 5.8-14.8 | |
| 625 M | |
| 70 542 K | |
| 0 | |
| 1.108 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
ORIC PHARMAC.INC.DL-0001 Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -124 064 000
- Earnings Per Share -1.63
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get ORIC PHARMAC.INC.DL-0001 Earnings via APIs
- Latest Release 2024-11-04
- EPS/Forecast NaN
Get ORIC PHARMAC.INC.DL-0001 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
